-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Satsuma Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2022.
- Satsuma Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$10.3M, a 33.7% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$64.8M, a 15.3% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$70.1M, a 36.9% decline from 2021.
- Satsuma Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$51.2M, a 7.59% decline from 2020.
- Satsuma Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$47.6M, a 68.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)